Alderson Broaddus University - WOWK 13 Charleston, Huntington WV News, Weather, Sports

Alderson Broaddus University

Posted: Updated:
  • PeopleMore>>

  • Jackson Kelly

    Jackson Kelly

    Friday, August 8 2014 11:00 AM EDT2014-08-08 15:00:22 GMT
    Danielle Swann has joined the Charleston office of Jackson Kelly.
    Danielle Swann has joined the Charleston office of Jackson Kelly.
  • HB&W Inc.

    HB&W Inc.

    Friday, August 8 2014 11:00 AM EDT2014-08-08 15:00:22 GMT
    George S. Weaver III has been elected chairman of the board of HB&W Inc.
    George S. Weaver III has been elected chairman of the board of HB&W Inc.
  • HOOPS Family Children’s Hospital

    HOOPS Family Children’s Hospital

    Friday, August 8 2014 11:00 AM EDT2014-08-08 15:00:20 GMT
    Dr. Kyle M. Smith, a fellowship-trained pediatric anesthesiologist, has joined Hoops Family Children’s Hospital, specializing in providing anesthesia care for children undergoing surgery.
    Dr. Kyle M. Smith, a fellowship-trained pediatric anesthesiologist, has joined Hoops Family Children’s Hospital, specializing in providing anesthesia care for children undergoing surgery.
PHILLIPI -

Yi Charlie Chen, professor of biology at Alderson Broaddus University, has been selected to join more than 350 cancer researchers from prominent research institutions in 31 countries in a project that hopes to tackle cancer's complexity. 

The initiative is called "The Halifax Project" and involves two separate task forces.

One task force will take what has been learned about cancer's complexity to design an entirely new approach to therapy, while the other will assess whether everyday exposures to mixtures of commonly encountered chemicals have a role to play in cancer causation. 

This collaborative international initiative is being led by a nongovernmental organization called "Getting to Know Cancer." Chen will be working on one of 12 cross-functional teams of scientists that will each be focused on a different aspect of cancer biology. 

The teams will spend the next year reviewing what is known about cancer's complexity to design a ground-breaking "broad-spectrum" therapeutic approach that will be aimed at many prioritized targets simultaneously.